{"doi":"10.1111/tid.14255","title":"Antibacterial prophylaxis for neutropenic and high‐risk hematology patients—Do the benefits outweigh the risk?","abstract":"Julian Lindsay has served on advisory boards for Mayne Pharma, MSD, Amgen, and BMS. Gemma Reynolds has no relevant disclosures. Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.","journal":"Transplant Infectious Disease","year":2024,"id":479633,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":1,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9457,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1318720,"name":"Julian Lindsay","orcid":"0000-0002-7086-538X","position":1,"is_corresponding":false},{"id":1318719,"name":"Gemma Reynolds","orcid":"0000-0002-9561-3592","position":0,"is_corresponding":true}],"reference_count":13,"raw_metadata":null,"created_at":"2026-07-19T02:06:54.284166Z","pmid":"38459753","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}